v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Current Assets:    
Cash $ 471,705 $ 1,041,899
Accounts Receivable (net of allowance of $0 and $0 respectively 77,429 109,589
Inventory 491,603 387,736
Other Current Assets 37,485 33,480
Total Current Assets 1,078,222 1,572,704
Total Assets 1,078,222 1,572,704
Current Liabilities    
Accounts Payable 353,696 459,703
Accrued expenses-related party 3,000
Total Liabilities 353,696 462,703
Stockholders’ Equity    
Series A preferred stock ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of September 30, 2021 and June 30, 2021, respectively) 1 1
Series B preferred stock ($0.001 par value, 5,000 shares authorized, and 4,227 and 4655 issued and outstanding as of September 30, 2021 and June 30, 2021, respectively) 4 5
Common stock ($0.001 par value, 200,000,000 shares authorized, and 85,090,986 issued and outstanding as of September 30, 2021 and 80,707,459 issued and outstanding as of June 30, 2021, respectively) 85,091 80,707
Additional paid in capital 26,959,911 26,226,159
Accumulated deficit (26,320,481) (25,196,871)
Total Stockholders’ Equity 724,526 1,110,001
Total Liabilities & Stockholders’ Equity $ 1,078,222 $ 1,572,704

Source